戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 line cortisol at 60 min of < 9 mug/dL) after cosyntropin (250 mug) administration and a random plasma
2 re (basal) and three times after intravenous cosyntropin (ACTH 1-24) injection.
3                                        Short cosyntropin (adrenocorticotropic hormone; ACTH) stimulat
4                                  Resting and cosyntropin-stimulated cortisol levels were obtained bef
5 Adrenal insufficiency was determined using a cosyntropin stimulation test in all studies.
6                                          The cosyntropin stimulation test is the initial endocrine ev
7 asia, is in place in many countries, however cosyntropin stimulation testing might be needed to confi
8 dary adrenal insufficiency for the high-dose cosyntropin test (P < 0.001), but AUCs for the 250-micro
9                                          The cosyntropin test performs well in patients with primary
10 95%, summary ROC analysis for the 250-microg cosyntropin test yielded a positive likelihood ratio of
11  secondary adrenal insufficiency (250-microg cosyntropin test), and secondary adrenal insufficiency (
12 nd secondary adrenal insufficiency (1-microg cosyntropin test), respectively.
13 or primary adrenal insufficiency (250-microg cosyntropin test), secondary adrenal insufficiency (250-
14 aracteristics of the 250-microg and 1-microg cosyntropin tests are similar.
15 1), but AUCs for the 250-microg and 1-microg cosyntropin tests did not differ significantly (P > 0.5)
16 specificity data for 250-microg and 1-microg cosyntropin tests; these curves were then compared by us
17                         Cortisol response to cosyntropin varies considerably among healthy persons.
18 level <20 microg/dL post-low-dose (1 microg) cosyntropin was considered diagnostic of adrenal insuffi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。